Brainsway has leased a Deep TMS system to Harvard University’s McLean Hospital.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.
Brainsway Ltd. (TASE:BRIN) has leased a Deep TMS (transcranial magnetic stimulation) device for the treatment of depression to Harvard University’s McLean Hospital, one of the leading psychiatric hospitals in the world. In line with Brainsway’s business model, payment will be based on the number of patients treated, with an annual minimum payment, except for the first year.
“I am very pleased that our marketing efforts are achieving results at leading centers in the US and other countries. We are also very pleased by the progress in clinical studies for various indications, ” said Brainsway CEO Uzi Soffer. “Brainsway has won global recognition, as reflected by numerous recent events, including the start of two multicenter clinical trials in the US with scores of top international researchers.”
Published by Globes [online], Israel business news – www.globes-online.com